-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
-
-
-
-
-
-
-
Corcept finds hypercortisolism in 27% of resistant hypertension patients
-
-
-
-
-
-
-
Corcept loses patent appeal against Teva over generic Korlym
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) PT Lowered to $99 at Canaccord Genuity
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) PT Lowered to $121 at Piper Sandler
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
-
453,559 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

